Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTCMKTS: CBIH), to fund the clinical data collection efforts of CBIH’s rigorous data clinical studies, underscoring Vita Biotech's...

Houston, Texas--(Newsfile Corp. - June 5, 2024) - Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTC Pink: CBIH), to fund the clinical data collection efforts of CBIH's rigorous data clinical studies, underscoring Vita Biotech's commitment to supporting cutting-edge research and ensuring the highest standards of clinical data integrity.

Houston, Texas--(Newsfile Corp. - May 29, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) announces the engagement of StoneBridge Advisory (stonebridgema.com) for CBIH's company valuation. The Colorado-based firm specializes in business valuations as well as mergers and acquisitions, boasting over three decades of experience in the industry. They represent businesses for sale, and their expertise lies in in-depth professional valuation reports that are IRS Revenue Ruling 59-60 compliant, and meet the Uniform Standards of Professional Appraisal Practice.

Houston, Texas--(Newsfile Corp. - May 20, 2024) - Cannabis Bioscience International Holdings(OTC Pink: CBIH), utilizing robust methodologies to safeguard its intellectual property and establish a well-defined company portfolio, has engaged Vereb Law Group PLLC (www.vereblawgroup.com), a reputable law firm with headquarters in Houston, which handles all aspects of intellectual property litigation, including matters related to patents, trademarks, copyrights, and trade secrets.

Houston, Texas--(Newsfile Corp. - May 6, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH), a leading company in the cannabis industry, proudly announces Mr. John E. Jones as its new Treasurer and Director.

Houston, Texas--(Newsfile Corp. - March 20, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) has announced the enrollment of the first patient for the clinical trial of its new intra-articular cannabinoid-based injection for knee osteoarthritis. The company plans to test the product on its first participant, and after careful collection and analysis of clinical outcomes, start enrollment of a bigger sample of patients to administer the treatment and further evaluate its efficacy.

Houston, Texas--(Newsfile Corp. - March 6, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that Dante Picazo, its chief executive officer, is contributing one billion shares of his common stock to the Company. These shares will be retired and have the status of authorized and unissued shares. As a result of this contribution, the number of the Company's outstanding shares has been reduced to approximately 9.4 billion. Since current management assumed control of the Company in 2019, its members have contributed 5.5 billion shares to the Company for no or nominal consideration. The shares have a market price of approximately $5 million, valued at the closing price of $0.0009 on March 5, 2024. The Company believes that Mr. Picazo's contribution will increase shareholder value.

Houston, Texas--(Newsfile Corp. - February 26, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce that Brian Cuban has been elected by our firm as an Advisory Board Member. Mr. Cuban will bring decades of experience in legal and corporate leadership, and a long track record of coaching diverse professionals around the world.

Houston, Texas--(Newsfile Corp. - February 20, 2024) - Cannabis Bioscience International Holdings, a Houston-based company trading on the OTC Markets under the ticker symbol CBIH, has engaged the services of Bull in Advantage as its Investor Relations firm.

Houston, Texas--(Newsfile Corp. - December 18, 2023) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH). CEO Dante Picazo sending a letter to all shareholders.

This Calls for a Celebration

via NewMediaWire – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File No. 333-267039) (the “Registration Statement”), filed under the Securities Act of 1933 (the “Securities...

via NewMediaWire -- Cannabis Bioscience International Holdings (trading on the OTC Markets under the ticker symbol CBIH), a medical research company that specializes in clinical trials and cannabinoids education, proudly announces the launch of its...

via NewMediaWire -- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus on traditional clinical trials and cannabinoids research, is excited to announce that FINRA...